CAS: 116209-55-3; (2S)-1-[4-[2-(Cyclopropylmethoxy)Ethyl]Phenoxy]-3-(Propan-2-Ylamino)Propan-2-Ol,Hydrochloride

该化合物是一种主要用于治疗青光眼和眼部高血压的选择性乙型-1肾上腺对抗物,作为乙型阻塞剂的一员,通过减少水性幽默生产来减少内腔压力.该物质的特点在于对乙型-1受体的高度选择性,这可以最大限度地减少与非选择性乙型阻塞体有关的潜在副作用.Levobetalogol通常作为一种眼滴溶液来施用,其药用植物动力涉及快速吸收和相对较短的半衰期,需要每天多剂量来有效管理眼压.盐盐的形态在水溶液中强化其溶性与稳定性,使之适合眼部配方.常见副作用可能包括:眼部不适,眼干燥或透视,而系统吸收则可能导致心血管效应,尽管由于局部应用,这些作用并不常见.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9757463-B2
    优先权日:2012-06-15
    标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
    发明人:HARTH EVA M; BEEZER DAIN B; LI GUANGZHAO; SPEARS BENJAMIN R; STEVENS DAVID M
    权利人:UNIV VANDERBILT
    摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:CN-1651379-A
    优先权日:2004-12-03
    标 题 :A new process for the synthesis of 4-[2-(cyclopropylmethoxy)ethyl]phenol

    专利号:US-9745419-B2
    优先权日:2014-01-24
    标 题 :Aqueous polyglycidol synthesis with ultra-low branching
    发明人:HARTH EVA M; SPEARS BENJAMIN R
    权利人:UNIV VANDERBILT
    摘要:Disclosed herein are glycidol-based polymers, nanoparticles, and methods related thereto useful for a variety of applications, including, but not limited to, drug delivery. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:WO-2024097977-A1
    优先权日:2022-11-04
    标题:Silk nanoparticle synthesis: tuning size, dispersity, and surface chemistry for drug delivery
    发明人:SHAIDANI SAWNAZ; FALCUCCI THOMAS; FOSTER OLIVIA; SAHOO JUGAL KISHORE; HASTURK ONUR; KAPLAN DAVID L; JACOBUS CHARLOTTE S
    权利人:TUFTS COLLEGE
    摘要:Methods disclosed herein relate to generating silk nanoparticles with a low polydispersity index (PDI). Methods include adding a silk solution dropwise into a volatile solvent that is miscible with water, thereby forming a precipitate-bearing solution and applying shear forces to the precipitate-bearing solution for a length of time sufficient to achieve evaporation of at least 95% of the volatile solvent, thereby producing a population of silk fibroin nanoparticles in water having a polydispersity index (PDI) of 0.35 or less, including but not limited to, a PDI of 0.330 or less, 0.325 or less, 0.315 or less, 0.310 or less, 0.30 or less, 0.275 or less, 0.250 or less, 0.225 or less, or 0.200 or less. Parameters related to silk fibroin molecular weight, silk fibroin concentration, shear force application, and temperature may all be modified to achieve silk nanoparticles of a particular size exhibiting particular PDIs.

    专利号:US-2016206743-A1
    优先权日:2012-06-15
    标题 :Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures

    专利号:US-2014005278-A1
    优先权日:2012-06-15
    标题 :Linear polyester and semi-linear glycidol polymer systems: formulation and synthesis of novel monomers and macromolecular structures
    安徽省庆云医药化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    电话:0551-3633067👤
    ⚠️参考联系方式
    邮件:klyyah@163.com
    销售经理: 黄经理
    联系电话:0551-3633067
    手机号码: 13505695656
    传真号码: 0551-3653208
    安徽省合肥市双凤工业区双凤大道金川路南025号
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    安徽省合肥市双凤工业区双凤大道金川路南025号
    ⚠️ 未注册 · 未认证企业
    注册入口 声明: 数据来源:本内容基于各搜索引擎等公开数据整理,仅作展示用。请自行辨别 📄若企业需抹除相关内容或, 请联系方我们,我们即刻栓除。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Quaranta L, Turano R, Pizzolante T. Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension. Clin Ophthalmol. 2007 Jun;1(2):93-7.
    2: Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2007 Nov;29(9):625-55.

    合成参考文献


    参考文献:10.1007/978-3-031-61073-8_15
    摘要:Wang C, Abbasian J. Medical Therapy of Childhood Glaucoma. 2024. In: Childhood Glaucoma.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知